Posts Tagged 'Actos and cancer'

Hissey Kientz publishes frequently asked questions for Actos bladder cancer

Hissey Kientz law firm has published a frequently asked questions section to provide more information about the diabetes medication Actos and bladder cancer to readers. The FAQs include information concerning who should not take Actos and certain risks associated with the drug.

Read more about the connection between Actos and bladder cancer…

Watson Can Sell Generic Actos Now, U.S. Judge Rules

Watson Pharmaceuticals Inc. may begin immediately marketing a generic version of Takeda (4502) Pharmaceutical Inc.’s diabetes drug Actos, a federal judge ruled, handing the U.S. Food and Drug Administration a defeat. U.S. District Judge Amy Berman Jackson in Washington today overturned an FDA decision that kept Watson from joining a period of shared exclusivity granted to the companies that are first to file for the right to market generic versions of branded drugs.

Read more about the new generic version of Actos…

AARP questions safety of Actos

The American Association of Retired Persons (AARP) has released a newsletter in which a segment called “Ask the Pharmacist” questions the safety of diabetes drug Actos. Dr. Armon B. Neel Jr. highlighted the risks of taking the drug, which have recently been at the center of Actos lawsuits.

Read more about the AARP Actos warning…

Consumer Reports warns against generic version of Actos

Consumer Reports has warned readers against using a generic version of Actos recently approved by the Food and Drug Administration. The consumer awareness organization recommends that patients ask their doctors if using the brand-name diabetes drug Actos or its new generic equivalent is necessary, and recommends it only for patients who have no other options.

Read more about the generic version of Actos…

Actos doubles bladder cancer risk, British study finds

A new study has confirmed that the diabetes medication Actos doubles the risk of developing bladder cancer among people who use the drug for at least two years. The Canadian study was published in the British Medical Journal (BMJ) and included more than 115,000 diabetes patients that were treated between 1988 and 2009.

Read more about Actos and bladder cancer…

FDA issues warning about Actos-bladder cancer link

The Food and Drug Administration has issued a warning that the diabetes drug Actos may increase a patient’s risk of developing bladder cancer. The agency stated that it plans to update the patient medication guide for Actos in order to alert patients that they may be at risk of developing bladder cancer by using the drug.

Click here to read more…

FDA issues Actos bladder cancer warning

The Food and Drug Administration has warned that some patients taking Actos may face an increase risk of developing bladder cancer. Actos became the world’s best selling diabetes drug after the FDA issued a previous warning about the cardiovascular side effects of Avandia.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.